Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes
- 15 March 2005
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 105 (6) , 2258-2265
- https://doi.org/10.1182/blood-2004-09-3421
Abstract
Aspergillus fumigatus (AF) is a ubiquitous mold and is the most common cause of invasive aspergillosis, an important source of morbidity and mortality in immunocompromised hosts. Using cytokine flow cytometry, we assessed the magnitude of functional CD4+ and CD8+ T-cell responses following stimulation with Aspergillus antigens. Relative to those seen with cytomegalovirus (CMV) or superantigen stimulation, responses to Aspergillus antigens were near background levels. Subsequently, we confirmed that gliotoxin, the most abundant mycotoxin produced by AF, was able to suppress functional T-cell responses following CMV or staphylococcal enterotoxin B (SEB) stimulation. Additional studies demonstrated that crude AF filtrates and purified gliotoxin inhibited antigen-presenting cell function and induced the preferential death of monocytes, leading to a marked decrease in the monocyte-lymphocyte ratio. Analysis of caspase-3 activation confirmed that gliotoxin preferentially induced apoptosis of monocytes; similar effects were observed in CD83+ monocyte-derived dendritic cells. Importantly, the physiologic effects of gliotoxin in vitro were observed below concentrations recently observed in the serum of patients with invasive aspergillosis. These studies suggest that the production of gliotoxin by AF may constitute an important immunoevasive mechanism that is mediated by direct effects on antigen-presenting cells and both direct and indirect effects on T cells.Keywords
This publication has 46 references indexed in Scilit:
- Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsBlood, 2002
- Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?Bone Marrow Transplantation, 2002
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Sequencing the Aspergillus fumigatus genomeThe Lancet Infectious Diseases, 2002
- Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospitalBone Marrow Transplantation, 2002
- Invasive Mold Infections in Allogeneic Bone Marrow Transplant RecipientsClinical Infectious Diseases, 2001
- Aspergillus fumigatusand AspergillosisClinical Microbiology Reviews, 1999
- Invasive AspergillosisClinical Infectious Diseases, 1998
- Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow TransplantationThe Journal of Infectious Diseases, 1997
- Incidence and risk factors for invasive fungal infections in allogeneic BMT recipientsBone Marrow Transplantation, 1997